Skip to main content

Table 4 Proposal for a minimal dataset for clinical evaluation, management, and follow-up on Malan syndrome

From: A deep phenotyping experience: up to date in management and diagnosis of Malan syndrome in a single center surveillance report

Intervention

Evaluation

Frequency and follow-up

Auxological evaluation

Evaluate habitus, measurement of weight, length/height, head circumference

Complete evaluation with measurement of weight, length/height, head circumference at diagnosis. Repeat auxological evaluation every six months during the first 2 years of life, then at least annually

 

Calculate BMI-SDS and calories intake, reassure about appropriateness in food intake. Variate diet. If < 2SDS evaluate calories intake

Refer to pediatrician for BMI-SDS surveillance (first evaluation after 2 years of age)

Orthopedic evaluation

Evaluate spine curvature, body length discrepancies, flat feet. When required involve specialized practitioners (e.g., orthopedic surgeon, physiatrist, physiotherapist). Perform skeletal Xray if needed

At diagnosis, then evaluate annually until puberty

 

Accurate anamnesis for bone fractures. Consider DXA

DXA should be performed during puberty or earlier if presence of pathologic fractures

Ophthalmologic evaluation

Perform Ophthalmologic/Orthoptic evaluation. Search for refractive errors, nystagmus, strabismus, polar cataract, and optic disk pallor. Consider VEP and ERG to assess conduction in visual pathway

At diagnosis, then annually until puberty

Neurological evaluation I.CNS anomalies

MRI at diagnosis with critical search for CCH, wide ventricles, brain atrophy and CM1. Consider specific evaluation of optic nerve at MRI to detect Optic Nerve hypoplasia

At diagnosis. If CM1 is detected at MRI perform imaging follow-up. If CM1 is associated to syringomyelia consider neurosurgeon evaluation for proper timing of the imaging

II.Neurovegetative symptoms

Symptoms may be subtle or aspecific (e.g., vomiting/nausea, dizziness fainting). Look for CM1 and consider neurologic evaluation. Exclude other causes (e.g., cardiologic/otolaryngology evaluation)

At diagnosis, evaluate possible appropriate drug therapy, subsequent follow up

III.Epilepsy and EEG anomalies

Perform EEG in asymptomatic patients, educate caregivers to promptly recognize subtle symptoms

At diagnosis. If EEG aspecific anomalies alone are detected: watch and wait strategy, especially in NFIX SV. In patients with NFIX microdeletions consider closer follow-up due to the higher risk in developing seizures

 

If onset of seizures: Perform neurological evaluation and EEG, if required start antiepileptic therapy

At diagnosis, then on neurological indication

Neuropsychiatric and Behavior evaluation

Perform neuropsychiatric and behavior evaluation Verify visuomotor abilities, noise sensitivity and photophobia. Suggest symptomatic aids (i.e., coloured glasses, recommend low voice tone) when appropriate to reduce anxiety outbursts

At diagnosis, then on neuropsychiatric indication

Orodental Odontoiatric evaluation

Evaluate ogival palate, tooth overgrowth, malocclusions, caries. Educate to proper dental care

At diagnosis, then annually or on specific indications

Gastrointestinal evaluation

Look for constipation and treat it. Perform abdominal ultrasound to look for hepatomegaly and/or kidney enlargement

At diagnosis. Refer to pediatrician for possible therapy of constipation

Neoplasm surveillance

No consistent evidence for strict neoplasm surveillance

None

Cardiological evaluation

Perform echocardiogram. Look for AD, MR, other CHD

At diagnosis. Refer to pediatrician for periodic clinical evaluation

Genetic counselling

Appropriate genomic/genetic testing to exclude parental mosaicism. Consider parental or gonadal mosaicism

At diagnosis. Prenatal counselling in families with a known MALNS offspring conceived by ART

  1. AD aortic dilatation, ART assisted reproductive technology, BMI-SDS Body Mass Index-Standard Deviation Score, CM1 Chiari malformation type 1, CNS central nervous system, CHD congenital heart disease, DXA dual energy absorptiometry, EEG electroencephalogram, ERG electroretinogram, MR mitral regurgitation, MRI magnetic resonance imaging, VEP visual evoked potentials